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Abstract
Fanconi Anemia is a rare autosomal recessive disorder characterized by various congenital
malformations, progressive bone marrow failure at a very young age and of solid tumors
development. The authors present a rare case of a squamous cell carcinoma of the hard palate in
a Fanconi Anaemia patient. The atypical clinical manifestation rendered the diagnosis more difficult.
This case, for age of appearance, sex and localization, is unique in international literature. We
recommend a quarterly follow up of the oral-rhino-pharynx complex in FA patients and to consider
as carcinomas, all oral lesions that last more than two weeks.
Background
Fanconi Anemia (FA) is a rare autosomal recessive syn-
drome (birth incidence of 1 per 350000), first described
in 1927 as a progressive lethal anaemia associated with
brown pigmentation of skin [1,2]. Subsequently, this
term was extended to a syndrome that includes pancyto-
penia with hypoplastic bone marrow, skeletal, renal and
ophtalmological malformations and chromosomal aber-
rations. The disease involves many organs including skin
and genitourinary, musculoskeletal, cardiovascular and
neurological systems. The clinical findings in FA patients
are hyperpigmentation, small reproductive organs in
males, kidney problems, thumbs and arm abnormalities,
skeletal anomalies of hip, spine or ribs, low birth weight,
short stature, growth retardation, defects of the tissue sep-
arating the heart chambers and mental retardation or
learning disabilitym [3,4]. Most cases of FA manifest anae-
mia symptoms during childhood. However, the symp-
toms may not become apparent until adulthood [5,6]. FA
patients are at risk for secondary malignancies, for exam-
ple leukaemia, squamous cell carcinoma and hepatocellu-
lar carcinoma [7-9]. The risk of squamous cell carcinoma
development is expecially high in the anogenital region as
well as the head and neck region [10] Increased suscepti-
bility of the oral cavity and anogenital region to local pre-
disposing factors, including environmental toxins and
viruses [5]. The authors report a new case of hard palate
squamous cell carcinoma in a FA patient. The clinical his-
tory and localization of the tumour make this case
unique.
Case report
The patient, a 27-year-old white male, was referred by a
private oral surgeon to our hospital for evaluation of a
hard palate lesion that had appeared six months before
(Figure 1). The lesion had been diagnosed initialing as
gingivitis by the private oral surgeon and treated with
local topical medicines without any remission.
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At the age of seven the patient was recovered for an ortho-
paedic trauma. He had been diagnosed with FA at the age
of seven after that pancytopenia was noticed during rou-
tine blood examinations for orthodontic trauma. He had
been treated with androgenic therapy and had not
received a bone marrow transplant. The haematological
test revealed an early stage of pancytopenia (3,4 × 109/l,
Hb 12,3 g/dl, and platelets 13 × 109/l).
Oral examination revealed a relatively well-defined,
nearly circular, concave ulcer measuring 3 × 4 cm, which
extended from the hard palatal mucosa in the upper
molar region to the adjacent soft palatal mucosa. The sur-
face was erythematous and smooth, with some tel-
angiectasias. Clinical examination showed no regional
lymphadenopathy. CT and MR imaging showed a hard
and soft tissue mass extending from molar region mucosa
to the soft palate mucosa. The nasopharynx appeared nor-
mal (Figure 2). No significant cervical lymphadenopathy
was seen on the images. An incisional biopsy performed
under local anaesthesia revealed a well-differentiated
squamous cell carcinoma (Figure 3).
The tumor was surgically removed with a right partial
maxillectomy extendiney to homolateral soft mucosa and
clear magins. Reconstruction was accomplished with a
temporalis muscle flap. The patient has been followed up
for 6 months without any evidence of recurrence or
metastasis.
Discussion
Fanconi Anemia is a rare autosomal recessive disorder
characterized by various congenital malformations, pro-
gressive bone marrow failure at a very young age and of
solid tumors development. FA is defined by its cellular
hypersensitivity to DNA cross-linking agent such as die-
poxybutane (DEB) and mitomycin (MML). Presence of
mutations of in one of the different FA genes, FA can be
divided into eight complementary groups (A, B, C, D1,
D2, E, F, G), with each group having in common the cel-
lular hypersensitivity to cross-linking agent. In the Inter-
national Fanconi Anemia Registry (IFAR)
complementation group A (65%), C (15%) and G (10%)
are the most common [11].
The severity is determined by specific complementation
group and over all by the type of genetic mutation.
Because of these phenotypic differences among comple-
mentation groups, FA is a heterogeneous disease. If
impaired genetic factors cause an early appearance of the
FA syndrome, the same factors may cause an early appear-
ance of malignancies. Thus, there are two distinct groups
of patients: (1) severe genetic disturbance with early FA
symptoms and early malignancies; (2) mild disturbances
with delayed FA symptoms and late malignancies [2].
Kaplan suggested that there are two defects determining
the development of cancer in FA patients: defective chro-
mosomal stability and immunodeficiency [12].
Patients that have endured bone marrow transplantation
have a greater incidence of malignancies development. In
these patients, there are four additional factors including
pretransplant total body irradiation, cyclophosphamide
treatment, chronic graft versus host disease, and pro-
longed immunosuppressive treatment after transplanta-
tion [2,13,14].
The highest incidence of cancer development in FA
patients is reported by Kuttler [11]. In this study he com-
pared the incidence of Hard Neck Squamous Cell Carci-
noma (HNSCC) in common population (0.038%) and in
FA patients (3%). The first to describe a HNSCC in a FA
patient were Esparza and Thompson [4]. Jansisyanont
reported that the commonest localizations of squamous
cell carcinoma in FA patients in descending order are:
tongue, anogenital region, pharynx, larynx, oral mucosa,
mandible and skin [13].
Lustig published a review of the international bibliogra-
phy on the HNSCC in FA patients [2]. He presented 17
cases. In 13 patients the cancer localization was intra-oral.
In 9 cases of these 13, the tongue was involved. According
with this, in FA patients the tongue cancer incidence is
69%, while in non FA patients the incidence varies by 10
to 16% [2].
Kuttler in 2003 referred that 19 of 754 patients in the
International Fanconi Anaemia Registry (3%) had
HNSCC [11]. In the same year Bremer presented two cases
of HNSCC [15], but in international literature no article
has reported a hard palate localization of HNSCC.
Preoperative hard and soft palate lesion Figure 1
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The male:female ratio of HNSCC in normal population is
2:1 while Reed asserted the reversed ratio in FA patients
[16]. FA patients develop squamous cell carcinoma at sig-
nificantly earlier age than the general population. Kenedy
and Hart reported an average age of 27 years in FA patients
[17] and the average time between age of FA diagnosis and
cancer development is 10.5 years [2].
The treatment of malignancies in FA patients with HNSCC
is similar to the general population with similar patholo-
gies. The aim is the tumour resection oncologic radicality.
The main preoperative problem in patients with FA is the
associated bone marrow failure, requiring preoperative
haematologic consultations. The possibility of blood and
platelet transfusion before surgery must be considered.
We think that the first approach in FA patients is surgical
resection of primary HNSCC with, if necessary, neck dis-
section and reconstruction. Generally, FA patients with-
stand surgical procedures very well. A further concern for
the surgeon is the development of postoperative compli-
cations, including wound infections and haematoma.
Although our patient did not develop postoperative com-
Preoperative CT image Figure 2
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plications, FA patients can have serious problems in adju-
vant therapy due to increased susceptibility to mutagenic
stimuli [2,11,13].
In FA patients, radiotherapy and chemotherapy follow
different therapeutic principles. In FA patients the
increased susceptibility to XRT and CTx can present prob-
lems to determine and to deliver a cancericidal dose with-
out causing significant damage to normal tissue. Thus, in
these patients standard doses for adjuvant therapy are
generally reduced. Furthermore, the use of conventional
protocols, which include cross-linking agents, can cause
severe systemic complications, including irreversible
aplastic anaemia and catastrophic organ damage [15,18].
Because SCC in FA is difficult to treat once advanced, it is
necessary to diagnose malignancies at early stage. We
agree with the protocol proposed by Kutler [11]. He sug-
gests a careful biannual screening of the oral cavity and
oropharynx that should start between the ages of 15 and
20. However, in patients with FA with histrory of leuco-
plakia or recurrent oral lesions, head and neck examina-
tions are recommended every six or eight weeks.
Conclusion
We report a unique localization of hard and soft squa-
mous cell carcinoma in a FA patient. The atypical clinical
manifestation rendered the diagnosis more difficult. We
recommend a quarterly follow up of the oral-rhino-phar-
Biopsy finding: Well-differentiated squamous cell carcinoma Figure 3
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ynx complex in FA patients and to consider as carcinomas,
all oral lesions that last more than two weeks.
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